Abdullah Alkhammash

6PUBLICATIONS
20CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 25, 2026
Quinazolinone-diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and in silico studies.

|Jun 05, 2026
Design, synthesis, and mechanistic evaluation of novel pyrazole/thiazole chalcone hybrids as dual tubulin polymerization and COX-2 inhibitors with potent antiproliferative activity.

|Mar 28, 2026
Discovery of a Novel Coumarin/Thiazole Chalcone Hybrid as a Potent Dual Inhibitor of Tubulin and Carbonic Anhydrases IX & XII with Promising Anti-Proliferative Activity.

Basima A A Saleem, Ashraf A Qurtam, Mohamed Ahmed

|Nov 27, 2025
Design, Synthesis, and Mechanistic Study of Novel Ciprofloxacin/Thiazole Chalcone Hybrids as Potential Anticancer Agents.

Hamada Hashem, Ali M Elshamsy, Safwat M Rabea

|Jan 25, 2025
Design, Synthesis, Anticancer Screening, and Mechanistic Study of Spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide Derivatives.

Ahmed M El-Saghier, Hamada Hashem, Sherif A Maher

|Nov 27, 2024
Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer.

Doaa Mohamed Elroby Ali, Hossameldin A Aziz, Stefan Bräse

Pageof 1

Frequent Collaborators

5 joint publications

Stefan Bräse

3 joint publications

Hamada Hashem

3 joint publications

Basima A A Saleem

2 joint publications

Kasim Sakran Abass